693 related articles for article (PubMed ID: 9168258)
1. Metabolism of the cytochrome P450 mechanism-based inhibitor N-benzyl-1-aminobenzotriazole to products that covalently bind with protein in guinea pig liver and lung microsomes: comparative study with 1-aminobenzotriazole.
Woodcroft KJ; Webb CD; Yao M; Weedon AC; Bend JR
Chem Res Toxicol; 1997 May; 10(5):589-99. PubMed ID: 9168258
[TBL] [Abstract][Full Text] [Related]
2. N-aralkylated derivatives of 1-aminobenzotriazole are potent isozyme- and lung-selective mechanism-based inhibitors of guinea pig cytochrome P-450 in vivo.
Knickle LC; Philpot RM; Bend JR
J Pharmacol Exp Ther; 1994 Jul; 270(1):377-85. PubMed ID: 8035335
[TBL] [Abstract][Full Text] [Related]
3. Kinetics and selectivity of mechanism-based inhibition of guinea pig hepatic and pulmonary cytochrome P450 by N-benzyl-1-aminobenzotriazole and N-alpha-methylbenzyl-1-aminobenzotriazole.
Sinal CJ; Bend JR
Drug Metab Dispos; 1996 Sep; 24(9):996-1001. PubMed ID: 8886610
[TBL] [Abstract][Full Text] [Related]
4. Mechanism-based inactivation of cytochrome P450 1A1 by N-aralkyl-1-aminobenzotriazoles in guinea pig kidney in vivo and in vitro: minimal effects on metabolism of arachidonic acid by renal P450-dependent monooxygenases.
Knickle LC; Webb CD; House AA; Bend JR
J Pharmacol Exp Ther; 1993 Nov; 267(2):758-64. PubMed ID: 8246152
[TBL] [Abstract][Full Text] [Related]
5. Mechanism-based inactivation of cytochrome P450 2B1 by N-benzyl-1-aminobenzotriazole.
Kent UM; Bend JR; Chamberlin BA; Gage DA; Hollenberg PF
Chem Res Toxicol; 1997 May; 10(5):600-8. PubMed ID: 9168259
[TBL] [Abstract][Full Text] [Related]
6. Significance of glycine 478 in the metabolism of N-benzyl-1-aminobenzotriazole to reactive intermediates by cytochrome P450 2B1.
Kent UM; Hanna IH; Szklarz GD; Vaz AD; Halpert JR; Bend JR; Hollenberg PF
Biochemistry; 1997 Sep; 36(39):11707-16. PubMed ID: 9305960
[TBL] [Abstract][Full Text] [Related]
7. Bioactivation of arachidonic acid by the cytochrome P450 monooxygenases of guinea pig lung: the orthologue of cytochrome P450 2B4 is solely responsible for formation of epoxyeicosatrienoic acids.
Knickle LC; Bend JR
Mol Pharmacol; 1994 Jun; 45(6):1273-80. PubMed ID: 8022420
[TBL] [Abstract][Full Text] [Related]
8. N-aralkyl derivatives of 1-aminobenzotriazole as potent isozyme-selective mechanism-based inhibitors of rabbit pulmonary cytochrome P450 in vivo.
Mathews JM; Bend JR
J Pharmacol Exp Ther; 1993 Apr; 265(1):281-5. PubMed ID: 8474011
[TBL] [Abstract][Full Text] [Related]
9. Three N-aralkylated derivatives of 1-aminobenzotriazole as potent and isozyme-selective, mechanism-based inhibitors of guinea pig pulmonary cytochrome P-450 in vitro.
Woodcroft KJ; Szczepan EW; Knickle LC; Bend JR
Drug Metab Dispos; 1990; 18(6):1031-7. PubMed ID: 1981509
[TBL] [Abstract][Full Text] [Related]
10. Selectivity and kinetics of inactivation of rabbit hepatic cytochromes P450 2B4 and 2B5 by N-aralkylated derivatives of 1-aminobenzotriazole.
Grimm SW; Bend JR; Halpert JR
Drug Metab Dispos; 1995 May; 23(5):577-83. PubMed ID: 7587934
[TBL] [Abstract][Full Text] [Related]
11. N-alkylaminobenzotriazoles as isozyme-selective suicide inhibitors of rabbit pulmonary microsomal cytochrome P-450.
Mathews JM; Bend JR
Mol Pharmacol; 1986 Jul; 30(1):25-32. PubMed ID: 3724742
[TBL] [Abstract][Full Text] [Related]
12. Metabolic activation of troglitazone: identification of a reactive metabolite and mechanisms involved.
He K; Talaat RE; Pool WF; Reily MD; Reed JE; Bridges AJ; Woolf TF
Drug Metab Dispos; 2004 Jun; 32(6):639-46. PubMed ID: 15155556
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of drug metabolism in rat liver slices: IV. Comparison of ethoxycoumarin clearance by liver slices, isolated hepatocytes, and hepatic microsomes from rats pretreated with known modifiers of cytochrome P-450 activity.
Carlile DJ; Hakooz N; Houston JB
Drug Metab Dispos; 1999 Apr; 27(4):526-32. PubMed ID: 10101148
[TBL] [Abstract][Full Text] [Related]
14. Differences in cytochrome P450-mediated biotransformation of 1,2-dichlorobenzene by rat and man: implications for human risk assessment.
Hissink AM; Oudshoorn MJ; Van Ommen B; Haenen GR; Van Bladeren PJ
Chem Res Toxicol; 1996 Dec; 9(8):1249-56. PubMed ID: 8951226
[TBL] [Abstract][Full Text] [Related]
15. Imipramine-induced inactivation of a cytochrome P450 2D enzyme in rat liver microsomes: in relation to covalent binding of its reactive intermediate.
Masubuchi Y; Igarashi S; Suzuki T; Horie T; Narimatsu S
J Pharmacol Exp Ther; 1996 Nov; 279(2):724-31. PubMed ID: 8930177
[TBL] [Abstract][Full Text] [Related]
16. Covalent binding of a reactive metabolite derived from propranolol and its active metabolite 4-hydroxypropranolol to hepatic microsomal proteins of the rat.
Narimatsu S; Arai T; Watanabe T; Masubuchi Y; Horie T; Suzuki T; Ishikawa T; Tsutsui M; Kumagai Y; Cho AK
Chem Res Toxicol; 1997 Mar; 10(3):289-95. PubMed ID: 9084908
[TBL] [Abstract][Full Text] [Related]
17. Effect of inducers of cytochrome P-450 on the metabolism of [3-14C]coumarin by rat hepatic microsomes.
Peters MM; Walters DG; van Ommen B; van Bladeren PJ; Lake BG
Xenobiotica; 1991 Apr; 21(4):499-514. PubMed ID: 1897250
[TBL] [Abstract][Full Text] [Related]
18. Metabolism and binding of cyclophosphamide and its metabolite acrolein to rat hepatic microsomal cytochrome P-450.
Marinello AJ; Bansal SK; Paul B; Koser PL; Love J; Struck RF; Gurtoo HL
Cancer Res; 1984 Oct; 44(10):4615-21. PubMed ID: 6380709
[TBL] [Abstract][Full Text] [Related]
19. In vitro studies on the metabolic activation of the furanopyridine L-754,394, a highly potent and selective mechanism-based inhibitor of cytochrome P450 3A4.
Sahali-Sahly Y; Balani SK; Lin JH; Baillie TA
Chem Res Toxicol; 1996 Sep; 9(6):1007-12. PubMed ID: 8870989
[TBL] [Abstract][Full Text] [Related]
20. Isozyme-selective metabolic intermediate complex formation of guinea pig hepatic cytochrome P450 by N-aralkylated derivatives of 1-aminobenzotriazole.
Sinal CJ; Bend JR
Chem Res Toxicol; 1995; 8(1):82-91. PubMed ID: 7703371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
